Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2024
-
Treace Medical Concepts Reports Third Quarter 2024 Financial Results
-
Assured Guaranty Insures $920 Million of Bonds as Part of $1.95 Billion JFK Airport Terminal 6 Redevelopment Project
-
Prothena to Report Third Quarter 2024 Financial Results on November 12
-
HeartCore Regains Compliance with Nasdaq Listing Requirements
-
Navitas Presents World’s First 8.5kW AI Data Center Power Supply Powered by GaN and SiC
-
Latham Group, Inc. Reports Third Quarter 2024 Financial Results
-
Pulmonx to Present at the Stifel 2024 Healthcare Conference
-
CARGO Therapeutics to Participate in Upcoming Investor Conferences
-
NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting
-
ResMed Announces Participation in the UBS Global Healthcare Conference
-
Winters & Yonker Announce the 2024 Holiday Give Back Program to Alleviate Hunger in Tampa Bay
-
Infinera Corporation Reports Third Quarter 2024 Financial Results
-
Revolve Group Announces Third Quarter 2024 Financial Results
-
Saturn Oil & Gas Inc. Reports Q3 2024 Results Highlighted by Record Quarterly Production, Adjusted EBITDA and Adjusted Funds Flow
-
Paysign, Inc. Reports Third Quarter 2024 Financial Results
-
Gulfport Energy Publishes 2023 – 2024 Corporate Sustainability Report
-
Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2024 Financial Results on November 12, 2024
-
Eos Energy Enterprises Reports Third Quarter 2024 Financial Results and Updates 2024 Outlook
-
SuperBuzz Issues Correction to the Debt Settlement Transaction that Closed on July 8, 2024
-
Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Mercury Systems Reports First Quarter Fiscal 2025 Results
-
Syndax Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Lumen Technologies reports third quarter 2024 results
-
Neurocrine Biosciences to Participate at Investor Conferences in November
-
Aviat Networks Announces Fiscal 2025 First Quarter and Three Month Financial Results
-
VTEX Reports Third Quarter 2024 Financial Results
-
National CineMedia, Inc. Reports Results for Fiscal Third Quarter 2024
-
MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results
-
Gulfport Energy Reports Third Quarter 2024 Financial and Operating Results and Expands Common Stock Repurchase Authorization by 54% to $1.0 Billion
-
Liberty Global to Present at the Morgan Stanley European Technology, Media & Telecom Conference
-
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Personalis to Present at the Stifel 2024 Healthcare Conference
-
Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
-
Eos Energy Signs Agreement with City Utilities of Springfield, Missouri to Provide 216 MWh of Energy Storage
-
United Fire Group, Inc. Reports Third Quarter 2024 Results
-
Ultragenyx Reports Third Quarter 2024 Financial Results and Corporate Update
-
Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update
-
Grocery Outlet Holding Corp. Announces Third Quarter Fiscal 2024 Financial Results
-
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
European Wax Center, Inc. to Report Third Quarter Fiscal Year 2024 Financial Results on November 14th
-
Xenon to Report Q3 2024 Financial Results on November 12, 2024
-
Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024
-
Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024
-
Huntsman Announces Fourth Quarter 2024 Common Dividend
-
Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024
-
agilon health to Participate at 2024 Wolfe Research Healthcare Conference
-
Maiden Holdings, Ltd. to Release Third Quarter 2024 Earnings on November 12, 2024
-
Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024
-
Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition

